{"organizations": [], "uuid": "63cb5a927f32386dd5e8fd3fd1173fc5a9b78f60", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/4", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/02/13/pr-newswire-aratana-therapeutics-to-report-fourth-quarter-and-full-year-2017-financial-results.html", "country": "US", "domain_rank": 767, "title": "Aratana Therapeutics to Report Fourth Quarter and Full Year 2017 Financial Results", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.006, "site_type": "news", "published": "2018-02-13T16:30:00.000+02:00", "replies_count": 0, "uuid": "63cb5a927f32386dd5e8fd3fd1173fc5a9b78f60"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/02/13/pr-newswire-aratana-therapeutics-to-report-fourth-quarter-and-full-year-2017-financial-results.html", "ord_in_thread": 0, "title": "Aratana Therapeutics to Report Fourth Quarter and Full Year 2017 Financial Results", "locations": [], "entities": {"persons": [], "locations": [{"name": "leawood", "sentiment": "none"}, {"name": "kan.", "sentiment": "none"}, {"name": "canada", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "aratana therapeutics, inc.", "sentiment": "neutral"}]}, "highlightText": "", "language": "english", "persons": [], "text": "LEAWOOD, Kan., Feb. 13, 2018 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative therapeutics for dogs and cats, will host a live conference call on Wednesday, March 14, 2018 at 8:30 a.m. ET to discuss financial results from the fourth quarter and full year ended December 31, 2017.\nInterested participants and investors may access the audio webcast or use the conference call dial-in:\n1 (866) 364-3820 (U.S.)\n1 (855) 669-9657 (Canada)\n1 (412) 902-4210 (International)\nA replay of the fourth quarter and full year 2017 results teleconference will be available the same day of the event by approximately 11 a.m. ET and an audio webcast will be accessible for 90 days in the Aratana Investor Room. For a replay of the call, use the below dial-in and conference ID 10117254:\n1 (877) 344-7529 (U.S.)\n1 (855) 669-9658 (Canada)\n1 (412) 317-0088 (International)\nAbout Aratana Therapeutics\nAratana Therapeutics is a pet therapeutics company focused on licensing, developing and commercializing innovative therapeutics for dogs and cats. As a pioneer in pet therapeutics, Aratana's mission is to deliver safe and effective therapeutics that elevate the standard of care in veterinary medicine. We work with companion animal veterinarians to bring new therapeutics to market that support the needs of pets and their owners. For more information, please visit www.aratana.com .\nContacts\nFor investor inquires:\nCraig Tooman\nctooman@aratana.com\n(913) 353-1026\nFor media inquiries:\nRachel Reiff\nrreiff@aratana.com\n(913) 353-1050\nView original content with multimedia: http://www.prnewswire.com/news-releases/aratana-therapeutics-to-report-fourth-quarter-and-full-year-2017-financial-results-300597487.html\nSOURCE Aratana Therapeutics", "external_links": ["http://www.prnewswire.com/news-releases/aratana-therapeutics-to-report-fourth-quarter-and-full-year-2017-financial-results-300597487.html", "https://www.webcaster4.com/Webcast/Page/421/24640", "http://www.aratana.com/"], "published": "2018-02-13T16:30:00.000+02:00", "crawled": "2018-02-13T18:38:33.005+02:00", "highlightTitle": ""}